Hearings to examine leveling the playing field, focusing on restoring America's edge in generic drug manufacturing.

Open Hearing Wednesday, September 23, 2026 · 3:30 PM EDT Hart Senate Office Building, Room 216

Committee

Source: congress.gov committee-meeting record (official page). Schedules can change; status reflects the latest we have.

Report a problem